PRTN3 and rheumatoid arthritis: The presence of other serological changes is also observed in the pre-symptomatic phase of RA; for example, a positive titre for anti-carbamylated (anti-CarP) antibodies precedes RA development in a subset of patients and is associated with a more severe disease course independently of ACPA [19–21].